Indoxyl Sulfate Aggravates Podocyte Damage through the TGF-β1/Smad/ROS Signalling Pathway

Miao Jia1, Lihua Lin1, Kang Xun1

  • 1Department of Nephrology, The People's Hospital of Suzhou New District, Suzhou, China.

Abstract

Insights

Indoxyl sulphate (IS) worsens diabetic nephropathy by increasing oxidative stress and altering TGF-β1/Smad signaling in podocytes. This study reveals IS impacts key proteins, offering new therapeutic targets for diabetic kidney disease.

Area of Science:

  • Nephrology
  • Diabetology
  • Molecular Biology

Background:

  • Diabetic nephropathy is driven by hyperglycemia-induced reactive oxygen species (ROS) and transforming growth factor β1 (TGF-β1)/Smad signaling.
  • Indoxyl sulphate (IS), a gut-derived uremic toxin, exacerbates podocyte injury via oxidative stress and inflammation.
  • The precise role of TGF-β1 signaling in IS-induced podocyte damage in diabetic nephropathy remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of Indoxyl Sulphate (IS) on podocyte injury markers.
  • To elucidate the involvement of reactive oxygen species (ROS) and the transforming growth factor β1 (TGF-β1)/Smad signaling pathway in IS-mediated podocyte damage.
  • To explore potential therapeutic strategies for diabetic nephropathy by understanding IS effects.

Main Methods:

  • Cultured differentiated rat podocytes in vitro.
  • Utilized quantitative real-time PCR (qRT-PCR) and Western blotting to measure protein and gene expression levels.
  • Manipulated TGF-β1 levels (silencing and overexpression), used a ROS inhibitor (acetylcysteine), and exposed cells to high glucose (HG) and IS.

Main Results:

  • High glucose (HG) conditions, when combined with TGF-β1 silencing or ROS inhibition, upregulated protective podocyte markers (nephrin, synaptopodin, CD2AP, SRGAP2a) and downregulated α-SMA.
  • Conversely, HG with TGF-β1 overexpression downregulated protective markers and upregulated α-SMA.
  • IS supplementation under HG conditions significantly reduced protective markers, altered Smad signaling components (Smad2/3, p-Smad2/3, Smad7), affected NOX4 expression, and increased ROS production.

Conclusions:

  • Indoxyl sulphate (IS) significantly contributes to podocyte damage in diabetic nephropathy.
  • IS modulates the expression of key podocyte proteins by regulating ROS production and the TGF-β1/Smad signaling pathway.
  • These findings offer novel theoretical support for developing treatments targeting IS, ROS, and TGF-β1/Smad pathways for diabetic nephropathy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K